The effect of androgen blockade on pulsatile gonadotrophin release and LH response to naloxone.
In order to clarify the effects of androgen blockade on the hypothalamic-pituitary-testicular axis in man, four patients with advanced prostate cancer, not previously treated, were given oral flutamide, 250 mg three times daily for 9 days. Before, and 7, 8 and 9 days after starting flutamide treatment, on separate days, the following tests were performed: a gonadotrophin pulsatility study, with 20 min interval blood sampling for 12 h, a naloxone test and a GnRH test. Flutamide induced a significant increase in both LH and FSH pulse frequency, while pulse amplitudes and plasma integrated concentrations (IC) of LH and FSH were unaffected. Plasma integrated concentrations of testosterone and oestradiol rose significantly, while that of prolactin was unaffected. The increase in plasma LH concentration induced by naloxone injection was abolished by flutamide treatment. On the other hand, the small FSH response to naloxone was unaffected by flutamide treatment. Response to GnRH was unaffected by flutamide. These results suggest that flutamide exerts effective androgen blockade at the hypothalamic level, since, despite increased plasma testosterone concentrations, gonadotrophin pulse frequency increased and the LH response to naloxone was abolished.
D000813:Anilides / Q000494:pharmacology*; D005485:Flutamide / Q000494:pharmacology* / Q000627:therapeutic use; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007986:Luteinizing Hormone / Q000097:blood*; D008297:Male; D009270:Naloxone; D010906:Pituitary Hormone-Releasing Hormones; D011471:Prostatic Neoplasms / Q000188:drug therapy; D013737:Testis / Q000187:drug effects
D000813:Anilides; D010906:Pituitary Hormone-Releasing Hormones; D009270:Naloxone; D005485:Flutamide; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone